Facile fabrication of magnetic metal–organic framework nanocomposites for potential targeted drug delivery

2011 ◽  
Vol 21 (11) ◽  
pp. 3843 ◽  
Author(s):  
Fei Ke ◽  
Yu-Peng Yuan ◽  
Ling-Guang Qiu ◽  
Yu-Hua Shen ◽  
An-Jian Xie ◽  
...  
2020 ◽  
Vol 103 ◽  
pp. 223-236 ◽  
Author(s):  
Vladimir R. Cherkasov ◽  
Elizaveta N. Mochalova ◽  
Andrey V. Babenyshev ◽  
Julian M. Rozenberg ◽  
Ilya L. Sokolov ◽  
...  

2021 ◽  
Author(s):  
Mostafa Fytory ◽  
Kholoud K. Arafa ◽  
Waleed El Rouby ◽  
Ahmed Farghali ◽  
Mahmoud Abdel-Hafiez ◽  
...  

Abstract In the last decade, nanosized metal organic frameworks (NMOFs) have gained an increasing applicability as multifunctional nanocarriers for drug delivery in cancer therapy. However, only a limited number of platforms have been reported that can serve as an effective targeted drug delivery system (DDSs). Herein, we report rational design and construction of doxorubicin (DOX)-loaded nanoscale Zr (IV)-based NMOF (NH2-UiO-66) decorated with active tumor targeting moieties; folic acid (FA), lactobionic acid (LA), glycyrrhetinic acid (GA), and dual ligands of LA and GA, as efficient multifunctional DDSs for hepatocellular carcinoma (HCC) therapy. The success of modification was exhaustively validated by various structural, thermal and microscopic techniques. Biocompatibility studies indicated the safety of pristine NH2-UiO-66 against HSF cells whereas DOX-loaded dual-ligated NMOF was found to possess superior cytotoxicity against HepG2 cells which was further confirmed by flow cytometry. Moreover, fluorescence microscopy was used for monitoring cellular uptake in comparison to the non-ligated and mono-ligated NMOF. Additionally, the newly developed dual-ligated NMOF depicted a pH-responsiveness towards the DOX release. These findings open new avenues in designing various NMOF-based DDSs that actively target hepatic cancer to achieve precise therapy.


RSC Advances ◽  
2018 ◽  
Vol 8 (12) ◽  
pp. 6581-6589 ◽  
Author(s):  
Fangpeng Shu ◽  
Daojun Lv ◽  
Xian-Lu Song ◽  
Bin Huang ◽  
Chong Wang ◽  
...  

DOX-doped MOF nanoparticles were prepared via a one-pot reaction and successively anchored with Fe3+ and HA for simultaneous targeted drug delivery and MR imaging.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Mostafa Fytory ◽  
Kholoud K. Arafa ◽  
Waleed M. A. El Rouby ◽  
Ahmed A. Farghali ◽  
Mahmoud Abdel-Hafiez ◽  
...  

AbstractIn the last decade, nanosized metal organic frameworks (NMOFs) have gained an increasing applicability as multifunctional nanocarriers for drug delivery in cancer therapy. However, only a limited number of platforms have been reported that can serve as an effective targeted drug delivery system (DDSs). Herein, we report rational design and construction of doxorubicin (DOX)-loaded nanoscale Zr (IV)-based NMOF (NH2-UiO-66) decorated with active tumor targeting moieties; folic acid (FA), lactobionic acid (LA), glycyrrhetinic acid (GA), and dual ligands of LA and GA, as efficient multifunctional DDSs for hepatocellular carcinoma (HCC) therapy. The success of modification was exhaustively validated by various structural, thermal and microscopic techniques. Biocompatibility studies indicated the safety of pristine NH2-UiO-66 against HSF cells whereas DOX-loaded dual-ligated NMOF was found to possess superior cytotoxicity against HepG2 cells which was further confirmed by flow cytometry. Moreover, fluorescence microscopy was used for monitoring cellular uptake in comparison to the non-ligated and mono-ligated NMOF. Additionally, the newly developed dual-ligated NMOF depicted a pH-responsiveness towards the DOX release. These findings open new avenues in designing various NMOF-based DDSs that actively target hepatic cancer to achieve precise therapy.


Materials ◽  
2018 ◽  
Vol 11 (5) ◽  
pp. 744 ◽  
Author(s):  
Huijun Li ◽  
Qingqing Li ◽  
Yaling He ◽  
Ning Zhang ◽  
Zhouqing Xu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document